1. Role: Director. Scope: Department. Date: 2019.
Grant H. Skrepnek, Ph.D., R.Ph.
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47105
Fax (4050 271-6430
Office CPB 214
Email grant-skrepnek@ouhsc.edu
Summary
I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Research
Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Publications & Presentations
- 31. Pham T T, Skrepnek G H, Bond C, Alfieri T, Cothran T J, Keast S. Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012-2016. Medical Care. 2018; 56 : 727-735
32. Pham T T, Keast S, Farmer K, Thompson D M, Rathbun C, Nesser N J, Holderread B P, Skrepnek G H. Sustained virologic response and costs associated with direct-acting antivirals for chronic hepatitis C infection in Oklahoma Medicaid. Journal of Managed Care and Specialty Pharmacy. 2018; 24 : 664-676
33. Pham T, Rathbun C, Keast S, Nesser N, Farmer K, Skrepnek G H. National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US. Journal of Evaluation in Clinical Practice . 2018
34. Fox A, Skrepnek G H, Miller J L, Schwier N C, Ripley T L. Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. American Journal of Cardiovascular Drugs . 2018
35. Combs D, Skrepnek G H, Seckeler M D, Barber B J, Morgan W J, Parthasarathy S. Sleep-disordered breathing is associated with increased mortality in hospitalized infants with congenital heart disease. Journal of Clinical Sleep Medicine. 2018; 14 : 1551-1558
Grants
- 11. Improving the Health of Americans through Prevention and Management of Diabetes, Heart Disease, and Stroke. Non-federal. Start Date: 2019. End Date: 2020.
12. Allergan (PI: Keast). Federal Non-NIH. Start Date: 2018. End Date: 2019.
13. Otsuka (Skrepnek/Keast PI). Non-federal. Start Date: 2018. End Date: 2019.
14. Research Fellowship. PhRMA. Start Date: 2017. End Date: 2018.
15. Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. Misc Non-Federal. Start Date: 2017.
Awards and Honors
no results
Education
no results
Administrative Assignments
2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.